Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

[Effects of phytoestrogens on prognosis and hormonal markers of breast cancer: A systematic review of randomized controlled trials].

Created on 02 Oct 2026

Authors

Laurence Poirier, Caroline Diorio

Published in

Bulletin du cancer. Oct 01, 2026. Epub Oct 01, 2026.

Abstract

Estrogen exposure is a known risk factor for breast cancer. Phytoestrogens, plant-derived compounds found in the diet, have a structure similar to estradiol. Observational studies suggest that they are associated with a reduced risk of breast cancer recurrence. The objective of this systematic review is to evaluate, based on data from randomized controlled trials, the effect of phytoestrogens on breast cancer prognosis and hormonal markers.
MEDLINE, EMBASE, CENTRAL, and ClinicalTrials.gov were searched from inception to February 2026, without language restrictions. Randomized controlled trials assessing the effect of phytoestrogens on breast cancer prognosis (recurrence and mortality) or on circulating estrogen concentrations (estradiol and estrone) were included. Risk of bias was assessed using the Cochrane RoB-2 tool. A qualitative synthesis was conducted due to study heterogeneity.
Four trials (1698 patients) were included. One trial (1542 patients) reported a non-significant reduction in recurrence risk (Relative risk 0.97; 95% Confidence Interval [CI] 0.75-1.27). No randomized trial evaluated mortality. Three trials (156 patients) reported non-significant decreases in estradiol concentrations. One trial (19 patients) showed a significant reduction in estrone concentration (Mean difference -5.50pmol/L; 95% CI -7.53 to -3.47).
Overall, the available data from trials remain limited and do not provide sufficient support for a protective effect. However, the trials did not report any increase in recurrence risk (1 trial) or circulating estrogen levels (3 trials), rather they suggested trends toward reduction. These findings should nevertheless be interpreted with caution given the limited number of studies available and their relatively small sample sizes.

PMID:
42823214
Bibliographic data and abstract were imported from PubMed on 02 Oct 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 18
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement